The influence of study results on therapeutic decisions -Experience in 35 years;Inwieweit bestimmen studienergebnisse therapeutisches handeln in der rheumatologie

Zeitschrift fur Rheumatologie

Volumn 61, Issue 5, 2002, Pages 504-515

  Rau, Rolf ^a  

^a Rheumatologische Klinik   (Germany)

Author keywords

Antirheumatic treatment; Clinical studies; Evidenced based medicine; Metaanalysis

Indexed keywords

AURANOFIN; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DICLOFENAC; IBUPROFEN; INDOMETACIN; INTERLEUKIN 1; LEFLUNOMIDE; MEFENAMIC ACID; METHOTREXATE; NABUMETONE; NAPROXEN; PENICILLAMINE; PIROXICAM; SALAZOSULFAPYRIDINE; SUDOXICAM; TENOXICAM;

CLINICAL TRIAL; DRUG APPROVAL; DRUG INDUSTRY; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; PRESCRIPTION; PUBLICATION; REVIEW; RHEUMATOLOGY;

ANTIRHEUMATIC AGENTS; AWARDS AND PRIZES; BIAS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; MULTICENTER STUDIES; PRODUCT SURVEILLANCE, POSTMARKETING; RANDOMIZED CONTROLLED TRIALS; RHEUMATIC DISEASES;

EID: 0036924817     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-002-0424-4     Document Type: Review

References (36)

1. Popper K (1994) Logik der Forschung. JCB Mohr (Paul Siebeck) Tübingen
2. Rogler G, Schölmerich J (2000) "Evidence-biased medicine" - Oder: Die trügerische sicherheit der evidenz. Dtsch Med Wschr 125:1122-1128
3. Sackett D, Haynes R, Tugwell P (1985) Clinical Epidemiology. Little, Brown & Company, Boston
4. Haagsma CJ, van Riel PL, de Jong AJ, van de Putte LB (1997) Combination of sulfasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomised, controlled, double-blind, 52 week clinical trial. Brit J Rheum 36:1082-1088
5. Dougados M, Combe B, Cantagrel A et al (1999) Combination therapy in early rheumatoid arthritis: A randomised, controlled, double-blind 52 week clinical trial of sulfasalazine and methotrexate compared with the single components. Ann Rheum Dis 58:220-225
6. Pincus T, Wolfe F, Callahan L (1994) Updating a re-assessment of traditional paradigms concerning rheumatoid arthritis. In: Wolfe F, Pincus T (eds) Rheumatoid Arthritis. Marcel Dekker, New York Basel Hongkong
7. Rau R (2000) Einführung in die basistherapie. In: Rau R (ed) Basistherapie der Rheumatoiden Arthritis. Unimed-Verlag, Bremen London Boston, S 114-130
8. Fries JF, Williams CA, Singh G, Ramey DR (1997) Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. J Rheumatol 24:838-844
9. Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586-1593
10. Rau R (2001) Have Traditional DMARDs had their Day? ILAR Congress Edmonton; publication in preparation
11. Fehlow W (1930) Goldbehandlung chronischer polyarthritiden. Münch Med Wschr 77:2215
12. Forestier J (1935) Rheumatoid arthritis and it's treatment by gold salts. J Lab Clin Med 20:827
13. Hartfall SJ, Garland HG, Goldie W (1937) Gold treatment of arthritis: A review of 900 cases. Lancet 233:838
14. Empire Rheumatism Council (1960) Gold therapy in rheumatoid arthritis. Ann Rheum Dis 19:95
15. Empire Rheumatism Council (1961) Gold therapy in rheumatoid arthritis. Final report of a multicentre controlled trial. Ann Rheum Dis 20:316
16. Gubner R, August S, Ginsberg V (1951) Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 221:176-182
17. Gross D, Enderlin M, Fehr K (1967) Die immunsuppressive behandlung der progredient chronischen polyarthritis mit antimetabolica und cytostatika. Schweiz Med Wschr 97:1301
18. Hoffmeister RT (1972) Methotrexate in rheumatoid arthritis (abstract). Arthritis Rheum 15:114
19. Willkens RF et al (1980) Low-dose pulse methotrexate in rheumatoid arthritis. J Rheumatol 7:501-505
20. Schattenkirchner M, Bröll H, Kaik B et al (1988) Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: A one-year double-blind comparative multicenter study. Klin Wochenschr 66:167-174
21. Williams HJ, Ward JR, Reading JC et al. (1992) Comparison of auranofin, methotrexate and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 35:1406-1407
22. Weinblatt ME, Kaplan H, Germain BF (1990) Low dose methotrexate compared with auranofin in adult rheumatoid arthritis. Arthritis Rheum 33:330-338
23. Willkens RF, Urowitz MB, Stablein DM et al (1992) Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 35: 849-856
24. Willkens RF, Sharp JT, Stablein DM, Marks CR, Wortman R (1995) Comparison of azathioprine, methotrexate and the combination of both in the treatment of rheumatoid arthritis. A 48 week controlled clinical trial with radiologic outcome assessment. Arthritis Rheum 38:1799-1806
25. Lipsky PE, van der Heijde DMFM, St. Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594-1602
26. Rau R, Wassenberg S (2002) Scoring methods, editorial. J Rheumatol 29: 653-655
27. Lassere M, Boers M, van der Heijde DMFM, Boonen A, Edmonds J et al (1999) Smallest detectable difference in radiological progression. J Rheumatol 26:731-739
28. Rau R, Wassenberg S, Zeidler H (2000) Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis. Z Rheumatol 59:II/90-96
29. Strand V, Cohen St, Schiff M et al (1999) Treatment of active rheumatoid arthritis with Leflunomide compared with placebo and methotrexate. Arch Intern Med 159:2542-2550
30. Jiang Y, Genant HK, Watt I et al (2000) A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 43:1001-1009
31. Dieppe P, Szebenyi B (2000) Evidence based rheumatology. J Rheumatol 27: 4-7
32. Alarcon GS, Lopez-Mendez A, Walter J et al. (1992) Radiographic evidence of disease progression in methotrexate-treated and nonmethotrexate disease modifying antirheumatic drugs treated rheumatoid arthritis patients. A meta-analysis. J Rheumatol 19: 1868-1873
33. Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S (1996) Low-dose corticosteroids in rheumatoid arthritis: A meta-analysis of their moderate-term effectiveness. Arthritis Rheum 39:1818-1825
34. Verhoeven AC, Boers M (1997) Limited bone loss due to corticosteroids; a systemic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 24:1495-1503
35. Dequeker J, Westhovens R (1995) Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and ist prophylaxis and treatment: Bones of contention. J Rheumatol 22: 1013-1019
36. Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR et al (2002) Etanercept versus methotrexate in patients with early rheumatoid arthritis. Arthritis Rheum 46:1443-1450